What is Offlimits?
Offlimits distinguishes itself in the competitive cereal market by offering products with unique ingredient profiles and health-conscious attributes. Their cereal lines, such as Dash featuring Intelligentsia coffee and cacao, and Zombie incorporating adaptogens like pandan and ashwagandha, cater to a modern consumer seeking organic, vegan, gluten-free, and lightly sweetened options. The company's commitment to whole ingredients and innovative flavor pairings positions it as a forward-thinking brand in the food industry.
How much funding has Offlimits raised?
Offlimits has raised a total of $2.3M across 1 funding round:
Unspecified
$2.3M
Unspecified (2021): $2.3M with participation from Dana Cowin, Science Inc., Moksha Fitzgibbons, Nick Tran, Canaan, Crosslink, and Marc Lotenberg
Key Investors in Offlimits
Canaan
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health. With offices in the U.S. and Israel and billions of dollars under management, Canaan has funded hundreds of startups and supported dozens of IPOs and acquisitions.
Crosslink
Crosslink is a privately held company with world class expertise in Electrochemistry and Polymer Science. Established in 1997, the company originally focused on creating EAP solutions in the laboratory. New leadership in 1999 brought an emphasis on commercializing products to bring step-change advancements to customers' products. Since then, the company has expanded its scientific and business team and created partnerships with leading universities in key technology areas. In addition, Crosslink forged alliances with the U.S. government and several significant industry leaders to fund development and commercialize products based on market needs.
Science Inc.
Science Inc. is an investment firm that focuses on building and investing in disruptive companies. They are known for their hands-on approach and their ability to help companies scale rapidly.
What's next for Offlimits?
The recent major strategic investment in Offlimits is poised to accelerate the company's expansion and product development initiatives. With a focus on scaling its unique offerings and potentially introducing new flavor profiles or product lines, Offlimits is strategically positioning itself for sustained growth. This capital infusion will likely support enhanced marketing efforts, broader distribution, and continued innovation in the health-conscious food market, reinforcing its brand presence and market share.
See full Offlimits company page
